4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-053597
President and CEO sold 42,000 shares at an average $21.04 ($883,680)
- President and CEO acquired 42,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2022-10-11 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-10-11 | Sale | −14,000 | $21.36 | $299,040 | 254,554 | D |
| Patel Sanjiv President and CEO | 2022-10-12 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-10-12 | Sale | −14,000 | $21.18 | $296,520 | 254,554 | D |
| Patel Sanjiv President and CEO | 2022-10-13 | Option exercise | +14,000 | $4.12 | $57,680 | 268,554 | D |
| Patel Sanjiv President and CEO | 2022-10-13 | Sale | −14,000 | $20.58 | $288,120 | 254,554 | D |
| Derivatives | |||||||
| Patel Sanjiv President and CEO | 2022-10-11 | Option exercise · Stock Option (Right to Buy) | −14,000 | 60,175 | D | ||
| Patel Sanjiv President and CEO | 2022-10-12 | Option exercise · Stock Option (Right to Buy) | −14,000 | 46,175 | D | ||
| Patel Sanjiv President and CEO | 2022-10-13 | Option exercise · Stock Option (Right to Buy) | −14,000 | 32,175 | D | ||
| Open-market sales · 42,000 sh · avg $21.04 · $883,680 | |||||||
Loading xslF345X03/doc4.xml…